Maintenance of plasma α-MSH after stroke may therefore not only be protective to the penumbra and BBB but can also enhance neuroplasticity mechanisms, and thus can extend the time window for treatment effect [11, 16]. The gene discussed is STAMBP; the disease is Stroke.